Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
43
INSM Quote, Financials, Valuation and Earnings
Last price:
$68.52
Seasonality move
:
19.62%
Day range:
$64.35 - $68.63
52-week range:
$21.92 - $84.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.92x
P/B ratio:
43.49x
Volume:
1.8M
Avg. volume:
2.1M
1-year change:
140.09%
Market cap:
$12.4B
Revenue:
$363.7M
EPS (TTM):
-$5.59
INSM Analysts' Consensus Rating
The 12 analysts providing 12-month price projections for Insmed shares anticipate an average target of $95.78, ranging from a low estimate of $67.26 to a high estimate of $110.00. This average target implies a growth of 39.68% compared to the current stock price of $68.57.
Consensus Price Target
$95.78
Highest Price Target
$110.00
Lowest Price Target
$67.26
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 12 | 12 | 12 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
INSM Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
